Unlike traditional treatments that target only CSF production, GLP-1 agonists may work through two pathways: Weight loss - a major long-term treatment for IIH Possible CSF pressure effects - GLP-1 receptors on the choroid plexus (where CSF is made) may reduce fluid secretion independent of weight loss The IIH Pressure Trial ( Brain , 2023) found that exenatide lowered intracranial pressure within hours of the first dose
Judge Marston oversees the MDL in the Eastern District of Pennsylvania
Short answer: nothe half-life is ~1 week regardless of whether youre on 0.25 mg, 0.5 mg, or higher
Fluid needs depend on your activity level, sex, and environment, among other factors
I regularly update this information based on the latest evidence around diet and GLP-1 medications
Keywords: CVOT, diabetes, GLP-1RA, oral semaglutide, PIONEER, weight loss INTRODUCTION Glucagon-like peptide 1 receptor agonists (GLP-1RAs) are one of the important classes of antidiabetic agents used in the management of type 2 diabetes